FR2977493B1 - Nouvelle composition anesthesique stable pour la reduction des reactions cutanees - Google Patents

Nouvelle composition anesthesique stable pour la reduction des reactions cutanees

Info

Publication number
FR2977493B1
FR2977493B1 FR1156041A FR1156041A FR2977493B1 FR 2977493 B1 FR2977493 B1 FR 2977493B1 FR 1156041 A FR1156041 A FR 1156041A FR 1156041 A FR1156041 A FR 1156041A FR 2977493 B1 FR2977493 B1 FR 2977493B1
Authority
FR
France
Prior art keywords
skin reactions
reducing skin
anesthetic composition
novel stable
stable anesthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1156041A
Other languages
English (en)
Other versions
FR2977493A1 (fr
Inventor
Thibaud Portal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1156041A priority Critical patent/FR2977493B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to PCT/EP2012/062731 priority patent/WO2013001073A1/fr
Priority to KR1020137034786A priority patent/KR20140145962A/ko
Priority to JP2014517739A priority patent/JP2014518239A/ja
Priority to CA2839179A priority patent/CA2839179A1/fr
Priority to BR112013033662A priority patent/BR112013033662A2/pt
Priority to CN201280032434.9A priority patent/CN103813806A/zh
Priority to EP12730563.9A priority patent/EP2726105A1/fr
Priority to US14/130,239 priority patent/US20140205589A1/en
Priority to RU2014102740/15A priority patent/RU2014102740A/ru
Publication of FR2977493A1 publication Critical patent/FR2977493A1/fr
Application granted granted Critical
Publication of FR2977493B1 publication Critical patent/FR2977493B1/fr
Priority to US14/693,361 priority patent/US20150297517A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR1156041A 2011-06-29 2011-07-05 Nouvelle composition anesthesique stable pour la reduction des reactions cutanees Expired - Fee Related FR2977493B1 (fr)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FR1156041A FR2977493B1 (fr) 2011-07-05 2011-07-05 Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
US14/130,239 US20140205589A1 (en) 2011-06-29 2012-06-29 New stable anesthetic composition for reducing skin reactions
JP2014517739A JP2014518239A (ja) 2011-06-29 2012-06-29 皮膚反応を低減するための新規な安定麻酔組成物
CA2839179A CA2839179A1 (fr) 2011-06-29 2012-06-29 Nouvelle composition anesthesique stable pour la reduction de reactions cutanees
BR112013033662A BR112013033662A2 (pt) 2011-06-29 2012-06-29 composição com taxa de degradação reduzida e/ou estabilidade melhorada de seus componentes e para diminuir ou aliviar ou mesmo eliminar reações cutâneas e método para diminuir ou aliviar ou mesmo eliminar reações cutâneas na qual é aplicada sobre um indivíduo que dela necessita
CN201280032434.9A CN103813806A (zh) 2011-06-29 2012-06-29 用于减少皮肤反应的新型稳定型麻醉剂组合物
PCT/EP2012/062731 WO2013001073A1 (fr) 2011-06-29 2012-06-29 Nouvelle composition anesthésique stable pour la réduction de réactions cutanées
KR1020137034786A KR20140145962A (ko) 2011-06-29 2012-06-29 피부 반응의 감소를 위한 신규의 안정한 마취 조성물
RU2014102740/15A RU2014102740A (ru) 2011-06-29 2012-06-29 Новая устойчивая анестетическая композиция для уменьшения кожных реакций
EP12730563.9A EP2726105A1 (fr) 2011-06-29 2012-06-29 Nouvelle composition anesthésique stable pour la réduction de réactions cutanées
US14/693,361 US20150297517A1 (en) 2011-06-29 2015-04-22 New stable anesthetic composition for reducing skin reactions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1156041A FR2977493B1 (fr) 2011-07-05 2011-07-05 Nouvelle composition anesthesique stable pour la reduction des reactions cutanees

Publications (2)

Publication Number Publication Date
FR2977493A1 FR2977493A1 (fr) 2013-01-11
FR2977493B1 true FR2977493B1 (fr) 2014-02-14

Family

ID=45375350

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1156041A Expired - Fee Related FR2977493B1 (fr) 2011-06-29 2011-07-05 Nouvelle composition anesthesique stable pour la reduction des reactions cutanees

Country Status (10)

Country Link
US (2) US20140205589A1 (fr)
EP (1) EP2726105A1 (fr)
JP (1) JP2014518239A (fr)
KR (1) KR20140145962A (fr)
CN (1) CN103813806A (fr)
BR (1) BR112013033662A2 (fr)
CA (1) CA2839179A1 (fr)
FR (1) FR2977493B1 (fr)
RU (1) RU2014102740A (fr)
WO (1) WO2013001073A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140329874A1 (en) * 2013-05-06 2014-11-06 Allergan, Inc. Alpha adrenergic agonists for the treatment of tissue trauma
US10039758B2 (en) 2014-10-24 2018-08-07 Keck Graduate Institute Of Applied Life Sciences Compositions and methods for inhibiting bacterial and viral pathogens
RU2571686C1 (ru) * 2014-10-28 2015-12-20 Ольга Марселевна Капулер Способ омоложения кожи лица у пациентов с анатомо-физиологическими особенностями лицевой части черепа
KR101682933B1 (ko) * 2016-07-14 2016-12-06 이정현 금을 함유한 진피 충진용 조성물
CN107252490B (zh) * 2017-07-12 2019-12-03 云平 一种局麻药物及其制备方法
WO2020065085A1 (fr) * 2018-09-28 2020-04-02 Galderma Research & Development Composition pharmaceutique comprenant de la brimonidine, et ses utilisations
CA3168712A1 (fr) * 2020-02-25 2021-09-02 The University Of North Carolina At Chapel Hill Compositions anesthesiques basees sur un eutectique et applications correspondantes

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
IE64891B1 (en) * 1990-03-15 1995-09-20 Becton Dickinson Co Composition for increased skin concentration of active agents by iontophoresis
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
IN185228B (fr) 1999-02-03 2000-12-09 Bakulesh Mafatlal Dr Khamar
US6147102A (en) * 1999-10-26 2000-11-14 Curatek Pharmaceuticals Holding, Inc. Clonidine preparations
US20050271596A1 (en) * 2002-10-25 2005-12-08 Foamix Ltd. Vasoactive kit and composition and uses thereof
MXPA06013649A (es) * 2004-05-25 2007-07-09 Sansrosa Pharmaceutical Dev In Compuestos, formulaciones, y metodos para tratar o prevenir desordenes inflamatorios de la piel.
US20060004094A1 (en) * 2004-07-02 2006-01-05 Agisim Gary R Composition and method for treating hemorrhoids and/or anorectal disorders
DK1863469T3 (da) * 2005-03-15 2012-03-26 Animal Ethics Pty Ltd Topisk analgesisk sammensætning
US20070154493A1 (en) * 2005-12-30 2007-07-05 Judy Hattendorf Method of treating skin needing botulinum toxin type a treatment
US20090093547A1 (en) * 2007-10-09 2009-04-09 Sciele Pharma, Inc. Compositions and Methods for Treating Premature Ejaculation
SI2818184T1 (sl) * 2007-11-16 2019-03-29 Aclaris Therapeutics, Inc. Sestava in postopki za zdravljenje purpure
EP2230910A4 (fr) * 2007-12-21 2011-04-13 Galderma Lab Inc Traitement pré-chirurgical
JP2012528130A (ja) * 2009-05-29 2012-11-12 ガルデルマ・リサーチ・アンド・デヴェロップメント アドレナリン受容体アゴニストα−１またはα−２、好ましくはブリモニジンの、充填剤、好ましくはヒアルロン酸との組み合わせ
US8394800B2 (en) * 2009-11-19 2013-03-12 Galderma Laboratories, L.P. Method for treating psoriasis
EP2371351A1 (fr) * 2010-04-01 2011-10-05 Charité Universitätsmedizin Berlin Composition pharmaceutique pour le traitement de l'urticaire solaire

Also Published As

Publication number Publication date
US20140205589A1 (en) 2014-07-24
US20150297517A1 (en) 2015-10-22
EP2726105A1 (fr) 2014-05-07
BR112013033662A2 (pt) 2017-03-01
WO2013001073A1 (fr) 2013-01-03
CN103813806A (zh) 2014-05-21
RU2014102740A (ru) 2015-08-10
KR20140145962A (ko) 2014-12-24
FR2977493A1 (fr) 2013-01-11
CA2839179A1 (fr) 2013-01-03
JP2014518239A (ja) 2014-07-28

Similar Documents

Publication Publication Date Title
HK1203218A1 (en) Use of template switching for dna synthesis dna
ZA201500808B (en) Composition for controlling plant disease and application therefor
BR112013000705A2 (pt) "composição de limpeza para cuidado pessoal"
BR302012002887S1 (pt) Configuração aplicada em garrafa para cuidado pessoal
BR112014006689A2 (pt) composição de cuidado oral
EP2701678A4 (fr) Composition cosmétique
BR112014013682A2 (pt) composição para cuidado pessoal
FR2977493B1 (fr) Nouvelle composition anesthesique stable pour la reduction des reactions cutanees
EP2753293A4 (fr) Compositions de polyamide pour soins personnels
PL2694021T3 (pl) Kompozycja gojąca do stosowania zewnętrznego
ZA201402433B (en) An aqueous photo-protective personal care composition
GB201202773D0 (en) Compositions for treatment of skin disorders
PL2729116T3 (pl) Kompozycje do higieny osobistej
IL231044B (en) Ionic tags for oligoribonucleotide synthesis
HK1193348A1 (en) Water-in-oil-type skin-whitening cosmetic
EP2732807A4 (fr) Composition cosmétique
FR2977491B1 (fr) Composition cosmetique comprenant un melange de miels
EP2755631A4 (fr) Composition de soins personnels à faible viscosité
IT1406864B1 (it) Composizione per il trattamento dell'acne
EP2732808A4 (fr) Composition cosmétique
EP2875731A4 (fr) Composition phytosanitaire et son application
DK2583571T3 (da) Forbedringer i forbindelse med skødeskind
EP2708230A4 (fr) Composition pour utilisation externe sur la peau pour des maladies inflammatoires
BR112014011723A2 (pt) composição antiperspirante
CL2014002666A1 (es) Composicion no acuosa para el cuidado bucal

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20240305